+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2019

  • ID: 4898144
  • Report
  • December 2019
  • Region: Global
  • 78 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Boston Scientific Corp
  • Conformal Medical Inc
  • CPC of America Inc
  • Essential Medical Inc
  • Mayo Clinic
  • Rex Medical LP
  • MORE
Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2019

Summary

The Medical Devices sector report, “Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2019“ provides an overview of Arteriotomy Closure Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Arteriotomy Closure Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Arteriotomy Closure Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Arteriotomy Closure Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Arteriotomy Closure Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Boston Scientific Corp
  • Conformal Medical Inc
  • CPC of America Inc
  • Essential Medical Inc
  • Mayo Clinic
  • Rex Medical LP
  • MORE
1 Introduction
1.1 Arteriotomy Closure Devices Overview

2 Products under Development
2.1 Arteriotomy Closure Devices - Pipeline Products by Stage of Development
2.2 Arteriotomy Closure Devices - Pipeline Products by Segment
2.3 Arteriotomy Closure Devices - Pipeline Products by Territory
2.4 Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
2.5 Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
2.6 Arteriotomy Closure Devices - Ongoing Clinical Trials

3 Arteriotomy Closure Devices - Pipeline Products under Development by Companies
3.1 Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development
3.2 Arteriotomy Closure Devices - Pipeline Products by Stage of Development

4 Arteriotomy Closure Devices Companies and Product Overview
4.1 Aporo Biomedical, Inc. (Inactive) Company Overview
4.1.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
4.2 Boston Scientific Corp Company Overview
4.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
4.3 CardioDex Ltd (Inactive) Company Overview
4.3.1 CardioDex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
4.4 CloSys Corp Company Overview
4.4.1 CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview
4.5 Conformal Medical Inc Company Overview
4.5.1 Conformal Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
4.6 Cor Habere Corp Company Overview
4.6.1 Cor Habere Corp Pipeline Products & Ongoing Clinical Trials Overview
4.7 CPC of America Inc Company Overview
4.7.1 CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview
4.8 Dextera Surgical Inc Company Overview
4.8.1 Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
4.9 Essential Medical Inc Company Overview
4.9.1 Essential Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
4.10 Harvard University Company Overview
4.10.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview
4.11 Mayo Clinic Company Overview
4.11.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
4.12 ProMed Inc Company Overview
4.12.1 ProMed Inc Pipeline Products & Ongoing Clinical Trials Overview
4.13 Rex Medical LP Company Overview
4.13.1 Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview
4.14 SentreHEART Inc Company Overview
4.14.1 SentreHEART Inc Pipeline Products & Ongoing Clinical Trials Overview
4.15 Sheba Medical Center Company Overview
4.15.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
4.16 Terumo Interventional Systems Company Overview
4.16.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
4.17 University of Rochester Company Overview
4.17.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
4.18 Vascular Closure Systems Inc Company Overview
4.18.1 Vascular Closure Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
4.19 Vivasure Medical Ltd. Company Overview
4.19.1 Vivasure Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5 Arteriotomy Closure Devices- Recent Developments
5.1 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships
5.2 Nov 07, 2019: Cardinal Health reports first quarter results for fiscal year 2020
5.3 Oct 30, 2019: Cardiva Medical announces publication of data From the AMBULATE pivotal study in the Journal of the American College of Cardiology: Clinical Electrophysiology
5.4 Sep 23, 2019: Conformal Medical announces presentation of US feasibility study data at TCT 2019 in San Francisco
5.5 Sep 18, 2019: Boston Scientific announces scheduled presentations at Transcatheter Cardiovascular Therapeutics 2019

6 Appendix
6.1 Methodology
6.2 About the Author
6.3 Contact Us
6.4 Disclaimer

List of Tables
Table 1: Arteriotomy Closure Devices - Pipeline Products by Stage of Development
Table 2: Arteriotomy Closure Devices - Pipeline Products by Segment
Table 3: Arteriotomy Closure Devices - Pipeline Products by Territory
Table 4: Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
Table 5: Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
Table 6: Arteriotomy Closure Devices - Ongoing Clinical Trials
Table 7: Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development
Table 8: Arteriotomy Closure Devices - Pipeline Products by Stage of Development
Table 9: Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Femoral Artery Closure Device - Product Status
Table 11: Femoral Artery Closure Device - Product Description
Table 12: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 13: WATCHMAN FLX - Product Status
Table 14: WATCHMAN FLX - Product Description
Table 15: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 16: WATCHMAN FLX - Compare Safety and Effectiveness of WATCHMAN FLX Left Atrial Appendage Closure (LAAC) and warfarin for Stroke Risk Reduction in Patients with Non-valvular Atrial Fibrillation (AF)
Table 17: WATCHMAN FLX - I Can See Left Atrial Appendage (ICELAA) Clinical Study
Table 18: WATCHMAN FLX - Protection Against Embolism for Non-valvular AF Subjects: Investigational Device Evaluation of the WATCHMAN FLX LAA Closure Technology
Table 19: WATCHMAN FLX - Watchman FLX Left Atrial Appendage Closure Device Post Approval Study
Table 20: CardioDex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 21: EpiClose Plus - Product Status
Table 22: EpiClose Plus - Product Description
Table 23: CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 24: CloSys HD - Product Status
Table 25: CloSys HD - Product Description
Table 26: Conformal Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Left Atrial Appendage Seal - LAA Occlusion - Product Status
Table 28: Left Atrial Appendage Seal - LAA Occlusion - Product Description
Table 29: Conformal Medical Inc - Ongoing Clinical Trials Overview
Table 30: Left Atrial Appendage Seal - LAA Occlusion - The CONFORMAL Early Feasibility Study an Evaluation of the Safety and Performance of the Conformal Left Atrial Appendage Seal for Left Atrial Appendage Occlusion
Table 31: Left Atrial Appendage Seal - LAA Occlusion - The Conformal Prague Study: An Evaluation of the Safety and Performance of the Conformal Left Atrial Appendage Seal for Left Atrial Appendage Occlusion
Table 32: Cor Habere Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 33: StrokeShield System - Product Status
Table 34: StrokeShield System - Product Description
Table 35: CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 36: MedClose - Product Status
Table 37: MedClose - Product Description
Table 38: Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: X-Port Vascular Access Closure Device - Product Status
Table 40: X-Port Vascular Access Closure Device - Product Description
Table 41: Essential Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: MANTA - Product Status
Table 43: MANTA - Product Description
Table 44: Essential Medical Inc - Ongoing Clinical Trials Overview
Table 45: MANTA - MANTA Versus Suture-based Closure after Transcatheter Aortic Valve Implantation Trial
Table 46: MANTA - Post-market Clinical Registry to Evaluate the Safety and Performance of MANTA Vascular Closure Device (VCD) Under Real World Conditions in the European Union (EU)
Table 47: Harvard University Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Access-Closure Device - Product Status
Table 49: Access-Closure Device - Product Description
Table 50: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Left Atrial Appendage Closure Device - Product Status
Table 52: Left Atrial Appendage Closure Device - Product Description
Table 53: ProMed Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Large Hole Closure Device - Product Status
Table 55: Large Hole Closure Device - Product Description
Table 56: Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Auto-Close Vascular Sealing System - Product Status
Table 58: Auto-Close Vascular Sealing System - Product Description
Table 59: Large Bore Closer Vascular Sealing System - Product Status
Table 60: Large Bore Closer Vascular Sealing System - Product Description
Table 61: SentreHEART Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Eclipse Surgical Left Atrial Appendage Closure Device - Product Status
Table 63: Eclipse Surgical Left Atrial Appendage Closure Device - Product Description
Table 64: Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Left Atrial Appendage Intraatrial Transcatheter Sutureless Closure - Product Status
Table 66: Left Atrial Appendage Intraatrial Transcatheter Sutureless Closure - Product Description
Table 67: Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Vascular Closure Device - Product Status

List of Figures
Figure 1: Arteriotomy Closure Devices - Pipeline Products by Stage of Development
Figure 2: Arteriotomy Closure Devices - Pipeline Products by Segment
Figure 3: Arteriotomy Closure Devices - Pipeline Products by Territory
Figure 4: Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
Figure 5: Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
Figure 6: Arteriotomy Closure Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3
  • Aporo Biomedical, Inc. (Inactive)
  • Boston Scientific Corp
  • CloSys Corp
  • Conformal Medical Inc
  • Cor Habere Corp
  • CPC of America Inc
  • Dextera Surgical Inc
  • Essential Medical Inc
  • Harvard University
  • Mayo Clinic
  • ProMed Inc
  • Rex Medical LP
  • SentreHEART Inc
  • Sheba Medical Center
  • Terumo Interventional Systems
  • University of Rochester
  • Vascular Closure Systems Inc
  • Vivasure Medical Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll